Form 8-K - Current report:
SEC Accession No. 0001558370-24-014642
Filing Date
2024-11-06
Accepted
2024-11-06 16:23:58
Documents
17
Period of Report
2024-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20241106x8k.htm   iXBRL 8-K 39870
2 EX-99.1 chrs-20241106xex99d1.htm EX-99.1 366312
3 GRAPHIC chrs-20241106xex99d1001.jpg GRAPHIC 6713
  Complete submission text file 0001558370-24-014642.txt   597006

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20241106.xsd EX-101.SCH 4529
5 EX-101.DEF chrs-20241106_def.xml EX-101.DEF 3159
6 EX-101.LAB chrs-20241106_lab.xml EX-101.LAB 12265
7 EX-101.PRE chrs-20241106_pre.xml EX-101.PRE 11152
19 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20241106x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 241431408
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)